Home » Topics » Regulatory

Regulatory
RSS

FDA approves Zolgensma for spinal muscular atrophy

May 27, 2019

Actemra approved in Japan for adult-onset Still's disease

May 23, 2019

FDA approves Venclexta with Gazyva for previously untreated CLL or SLL

May 16, 2019

FDA approves Bavencio with Inlyta for advanced renal cell carcinoma

May 15, 2019

FDA approves Eylea to treat all stages of diabetic retinopathy

May 14, 2019

FDA approves Cyramza for hepatocellular carcinoma previously treated with sorafenib

May 13, 2019

Waylivra receives conditional marketing authorization from the European Commission

May 8, 2019

FDA approves Ruzurgi for pediatric patients with Lambert-Eaton myasthenic syndrome

May 7, 2019

FDA approves Kadcyla for adjuvant treatment in HER2-positive early breast cancer setting

May 6, 2019

Qternmet XR approved in U.S. for type 2 diabetes

May 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...